At the end of Q3 in 2024, Allegiant Air expected to take just a single Boeing 737 MAX 8-200 delivery by the end of the year.
CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...